J B Chemicals & Pharmaceuticals Ltd

Small Cap

Healthcare Sector

reflects a positive outlook for the share price

reflects a neutral outlook for the share price

reflects a negative outlook for the share price

The analysts information is for reference only and does not\n  represents an investment recommendation.

Analyst recommendation reflect the views of analysts who follow and write research reports.

Company Information is an introduction to the company’s business that details what it sell, how it was founded, what their mission is, how they manufacture or source their products, and why they serve customers.

JB Chemicals & Pharmaceuticals emphasizes its robust product portfolio and financial performance, targeting a price range of ₹1,725-1,760 in one month, while noting potential risks.

JB Chemicals Sets Target Price Amid Strong Performance - 02 May, 2025

JM Financial has a buy call on J B Chemicals with a target price of Rs 2,225. However, potential suspension of Ranitidine could impact revenues by 5-6%. The company reported a net profit of Rs 162.49 crore for the latest quarter.

J B Chemicals Faces Challenges Amid Buy Call - 25 Apr, 2025

JB Chemicals & Pharmaceuticals Ltd. has announced a conference call on May 15, 2025, to discuss its fourth-quarter results and future outlook, providing insights for investors and analysts.

JB Chemicals Schedules Investor Call for Q4 Results - 23 Apr, 2025

J B Chemicals & Pharmaceuticals Ltd boasts a market cap of Rs 24,510 crores, with a 5-year stock return of 475.53%. The company reports a 19.03% return on equity, 5-year CAGR net profit growth of 23.29%, and revenue growth of 16.22%.

J B Chemicals Shows Strong Financial Performance - 19 Apr, 2025

J B Chemicals & Pharmaceuticals has received USFDA approval to market Bisoprolol tablets, a generic version of Teva's Zebeta, for treating hypertension.

J B Chemicals Receives USFDA Approval for Generic Drug - 18 Apr, 2025

J B Chemicals & Pharmaceuticals Ltd has approved the acquisition of up to 70 lakh equity shares of Jamnagar Renewables One Pvt. for Rs 7 crore. This investment aims to facilitate the consumption of power generated from a hybrid solar and wind power project.

J B Chemicals Approves Investment in Renewable Energy - 15 Apr, 2025

Price to Earnings Ratio or Price to Earnings Multiple is the ratio of the share price of a stock to its earnings per share (EPS). It provides an indication of whether a stock at its current market price is expensive or cheap.

The price/earnings-to-growth ratio, or the PEG ratio, is a metric that helps investors value a stock by taking into account a company's market price, its earnings, and its future growth prospects.

Enterprise value (EV) is the total value of a company, defined in terms of its financing. It includes both the current share price (market capitalization) and the cost to pay off debt (net debt, or debt minus cash).

Alpha measures the amount that the investment has returned in comparison to the market index or other broad benchmark that it is compared against.

Beta measures a stock's volatility, the degree to which its price fluctuates in relation to the overall stock market. In other words, it gives a sense of the stock's risk compared to that of the greater market.

Dividend yield measures the quantum of earnings by way of total dividends that investors make by investing in that company.

The debt-to-total-assets ratio shows how much of a business is owned by creditors (people it has borrowed money from) compared with how much of the company's assets are owned by shareholders.

Operating cash flow (OCF) is a measure of the amount of cash generated by a company's normal business operations. Operating cash flow indicates whether a company can generate sufficient positive cash flow to maintain and grow its operations.

This widget shows the information about the stock's peers in consideration along with the different data for those peers so that the user can compare the stock with the other similar stock and invest accordingly.

Promoter holding is the amount of share of the company that is owned by the promoters. The promoters are the company's founders, who hold a majority stake in the company's capital.

A foreign institutional investor (FII) is an investor or investment fund investing in a country outside of the one in which it is registered or headquartered.

A mutual fund is a pool of money managed by a professional Fund Manager. It is a trust that collects money from a number of investors who share a common investment objective and invests the same in equities, bonds, money market instruments, and other securities.

Retail investors execute their trades through traditional or online brokerage firms or other types of investment accounts. Retail investors purchase securities for their own personal accounts and often trade in dramatically smaller amounts as compared to institutional investors.

This widget shows the bifurcation of stocks based on the percentage of stake with the different types of shareholders.

This widget will help value the stock based on the Price to Earning ratio of the stock and compare the valuation with the industry value and other similar stocks. It even shows the timeline of the valuation of the stock and its highest and lowest valuation over time.
A Time Series data is provided which compares the historical stock PE with Industry PE over the period of 5 years.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

Foreign Institutions have increased holdings from 14.64% to 18.30% in Mar 2025 quarter

This section gives you an insight into how the FII Holding has changed for the stock over last few quarters.

FII Holding Up

Mutual Funds have increased holdings from 14.57% to 16.26% in Mar 2025 quarter

This section gives you an insight into how the Mutual Funds Holding has changed for the stock over last few quarters.

MF Holding Up

Netprofit is down for the last 3 quarters, 176.83 Cr → 162.49 Cr (in ₹), with an average decrease of 4.1% per quarter

This section gives you an insight into how the profit for the company has been for the last few quarters.

Profit Down

Retail Investor have decreased holdings from 15.29% to 15.14% in Mar 2025 quarter

This section gives you an insight into how the Retail Investors Holding has changed for the stock over last few quarters.

Retail Holding Down

Promoters have decreased holdings from 53.66% to 47.84% in Mar 2025 quarter

This section gives you an insight into how the Promoter Holding has changed for the stock over the last few quarters.

Promoter Holding Down

In the last 1 year, JBCHEPHARM stock has moved down by -16.6%

This section gives you an insight into the price movement of the stock for the last few quarters.

Price Dip

Revenue is down for the last 2 quarters, 1.01K Cr → 971.49 Cr (in ₹), with an average decrease of 3.9% per quarter

This section gives you an insight into how the revenue of the company has moved for the last few quarters.

Revenue Fall

S&P BSE SmallCap Select

BSE Healthcare

S&P BSE 250 SmallCap

BSE Small-Cap

NIFTY PHARMA

Nifty MidSmallcap 400

Nifty 500

S&P BSE 400 MidSmallCap

Nifty MNC

Nifty Smallcap 250

BSE 500

Kotak Emerging Equity Scheme Direct Growth

Axis Small Cap Fund Direct Growth

Franklin India Smaller Companies Fund Direct Growth

Canara Robeco Small Cap Fund Direct Growth

Kotak Small Cap Direct Growth

J B Chemicals & Pharmaceuticals Ltd’s net profit jumped 21.65% since last year same period to ₹162.49Cr in the Q3 2024-2025. On a quarterly growth basis, J B Chemicals & Pharmaceuticals Ltd has generated -6.92% fall in its net profits since last 3-months.

Name	Value	Action
MACD level (12,26)	0.47	Bullish
CCI (20)	494.46	Bearish
RSI (14)	49.83	Neutral
Momentum (10)	-0.6	Bearish
ADI (14)	19.22	Neutral
Ultimate Oscillator (7,14,28)	31.23	Neutral

Name	Value	Action
SMA (20)	1576	Bearish
EMA (20)	1576.13	Bearish
VWMA (20)	1576.4	Bearish
SMA (50)	1575.71	Bullish
EMA (50)	1575.76	Bullish
SMA (200)	1574.99	Bullish
EMA (200)	1577.7	Bearish
KAMA (200)	1575.62	Bullish
DEMA (200)	1572.13	Bullish

J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM)

Summary

Overall

Oscillators

Moving Averages